Все публикации

0:04:43

Implications for driving based on the risk of seizures after ischaemic stroke

0:03:48

Neurodegenerative disease risk among former international rugby union players

0:04:02

Anticoagulants do not always prevent stroke in atrial fibrillation

0:03:33

Results of the COMPARE trial of Constraint-induced or Multimodality Aphasia Therapy

0:03:49

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease

0:19:38

Parkinson’s Disease: the efficacy of L-Dopa therapy. Editor: Andrew Lees

0:10:22

Stroke: Introduction of thrombolysis and endovascular recanalisation therapy

0:09:28

Brain Imaging: The development and application of imaging techniques

0:03:51

Newborn screening for spinal muscular atrophy with disease-modifying therapies

0:03:44

Characteristics and outcomes of COVID-19-associated stroke

0:04:21

Efficacy and safety of adjunctive lacosamide in the treatment of PGTCS

0:04:01

Functional, cognitive and physical outcomes 3 years after minor lacunar or cortical ischaemic stroke

0:12:37

Intrathecal baclofen therapy vs conventional medical management for severe poststroke spasticity

0:06:34

Approaches to neuromodulation for schizophrenia

0:03:51

Meta-analysis of modifiable risk factors for Alzheimer's disease

0:19:28

Motor neurone disease: A clinical deconstruction

0:04:05

Meet JNNP and JNIS

0:04:07

Retinal nerve fibre layer thinning is associated with drug resistance in epilepsy

0:06:05

Post-stroke fatigue: a problem of altered corticomotor control?

0:44:42

Presymptomatic treatment for the dementias: plausibility and perils